Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fasted Conditions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
Primary objective of the present study was to assess the relative bioavailability of two
formulations of Extended Release Alfuzosin 10 mg under Fasted conditions, in healthy adult
male subjects after an oral administration with 7 days washout period.
Study Design:
Open-Label, Randomised, two Period, two treatment, Crossover, Single-Dose Bioequivalence
Study